Back to Results
First PageMeta Content
Tyrosine kinase receptors / Ribbon symbolism / Trastuzumab / HER2/neu / Exosome / Breast cancer / Lapatinib / Targeted therapy / Metastatic breast cancer / Chemistry / Medicine / Biology


A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression September 27, 2011 James A. Joyce Chairman & CEO, Aethlon Medical, Inc
Add to Reading List

Document Date: 2015-06-16 14:52:42

Open Document

File Size: 177,58 KB

Share Result on Facebook
UPDATE